Clinical Trial Update: Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)

View source ↗

Summary

The MINDSET trial, a multi-marker index for risk assessment of sepsis in the emergency department, sponsored by Abbott RDx Cardiometabolic, has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Snippet

Sponsor: Abbott RDx Cardiometabolic | Conditions: Sepsis | Status: WITHDRAWN